Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jan 23, 2009

NEW YORK (GenomeWeb News) - James Mazzo has resigned as a member of Beckman Coulter’s board of directors. The company said in a filing with the US Securities and Exchange Commission that Mazzo’s resignation was related to Abbott Laboratories' acquisition of Advanced Medical Optics, where he is chief executive officer, president, and chairman, and it was not related to any disagreement with Beckman Coulter.

Former US Food and Drug Administration Deputy Commissioner Scott Gottlieb has joined Combimatrix's board of directors. Gottlieb was deputy commissioner for medical and scientific affairs, senior advisor for medical technology, and director of medical policy development.

NextBio has appointed Andrew Grygiel to be VP of marketing. Grygiel previously was senior VP of global marketing at Orchestria, VP of global industries for EMC’s content management and software group, and VP of life sciences at Documentum. He also has held senior management roles at InnaPhase, Hewlett-Packard, and at Perkin-Elmer.

Qiagen has named Tom Clement to be VP of regulatory and clinical affairs. Clement came to Qiagen from Roche Molecular Systems, where he was VP of quality and regulatory, and he previously worked at Amersham, Organon, and Teknika.

GeneNews’ Chief Financial Officer, VP of Finance, and Treasurer Colin West has resigned from the company, which he will leave on March 31. The board of directors has named Sonny Young to take over the role of VP of finance and treasurer. The company also has named Gino Ariano to serve as senior director of the Sentry business unit, which markets the ColonSentry product in Canada. Young previously was director of corporate compliance for Occulogix, and he was controller at Sanofi-Synthelabo and director of financial accounting at TLC Vision. Ariano was a national sales manager at Medtronic Canada and he spent nine years at Glaxo Canada.

Luminex this week said that Executive VP and COO Douglas Bryant has stepped down from his job in order to become president and CEO of diagnostics firm Quidel in San Diego.

Guenter Bauer took over the role of chief business officer of Scienion at the beginning of January. Bauer formerly was CBO at Evotec and he was director of business collaboration in PerkinElmer's cellular technologies business.

Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People in the News, a weekly roundup of industry comings and goings.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.